EANO Educational Day - Thursday, September 21, 2023
Note that the programme is subject to change and will be continuously updated.
All times below refer to Central European Summer Time (CEST).
08:55-10:00 hrs
Chairs: tbc
EDB01.1 Phase 0 and window-of-opportunity studies
Susan Chang, United States
EDB01.2 Blood brain barrier and drug delivery
Olaf van Tellingen, Netherlands
EDB01.3 Blood brain barrier and drug delivery
Riccardo Soffietti, Italy
Chairs: tba
EDC01.1 Craniopharyngioma
Conor Mallucci, United Kingdom
EDC01.2 Malignant meningiomas
Matthias Preusser, Austria
EDC01.3 Germ cell tumours in young adults
Didier Frappaz, France
Chairs: tba
EDN01.1 Neuro-oncological practice in the Netherlands
Claudine Nogarede-Bloemendaal, Netherlands
EDN01.2 Transitions services for teenagers and young adults
Charly Granville George, United Kingdom
EDN01.3 Careplanning for improving survivorship
Cecilia Skoglund, Sweden
EDN01.4 Improved management of fatigue - a co-creation process
Rachael Simms-Moore, United Kingdom
10:00-10:10 hrs | BREAK
10:10-11:30 hrs
Chairs: tba
EDB02.1 The glioma cytoskeleton: from cell behaviour to biomarker
Elly Hol, Netherlands
EDB02.2 Meningeal lymphatics and brain tumours
Jasmin Herz, United States
EDB02.3 Perivascular niche in glioma and brain metastases
Frank Winkler, Germany
EDB02.4 T cell recognition and immunogenomics in gliomas and metastasis
Gavin Dunn, United States
chairs: tba
EDC02.1 Latest in surgery for gliomas
Marike Broekman, Netherlands
EDC02.2 Latest in radiation therapy for gliomas
Elizabeth Moyal, France
EDC02.3 Latest in drug and targeted therapies in gliomas
Enrico Franceschi, Italy
EDC02.4 Latest in supportive care for patients with gliomas
Filip de Vos, Netherlands
11:30-12:00 hrs | COFFEE BREAK
12:00-13:15 hrs
chair: tba
EDB03.1 Genomics and epigenomics
Roel Verhaak, United States
EDB03.2 Metabolomics
Richard Mair, United Kingdom
EDB03.3 Imaging heterogeneity
Chao Li, United Kingdom
Chairs: tba
EDC03.1 EANO Guidelines for testing for targetable mutations
Martin van den Bent, Netherlands
EDC03.2 Emerging targets for brain tumours
Juanita Lopez, United Kingdom
EDC03.3 Neurological complications from targeted therapy and immunotherapy
Marjolein Geurts, Netherlands
chair: tba
EDN02.1 The use of biomarkers in understanding caregiver distress and symptoms
Paula Sherwood, United States
EDN02.2 Group intervention for caregivers - an overview and the way forwards
Sara Nordentoft, Denmark
EDN02.3 Caregiver needs and support
Florien Boele, United Kingdom
EDN02.4 Connecting families in conversations and family-reported outcome - what is the effect?
Karin Piil, Denmark
13:15-14:00 hrs | LUNCH BREAK
14:00-15:20 hrs
Chairs: tba
EDB04.1 Resistance to radiotherapy
Susan Short, United Kingdom
EDB04.2 Resistance to chemotherapy
Mehdi Touat, France
EDB04.3 Resistance to immunotherapy
Michael Platten, Germany
EDB04.4 Harnessing 3D models of brain metastases to study therapeutic resistance and biomarkers
Manuel Valiente, Spain
Chair: tba
EDC04.1 Update on immunotherapy for brain metastases
Anna Berghoff, Austria
EDC04.2 Assessing response in brain metastases
Anouk van der Hoorn, Netherlands
EDC04.3 Redefining the role of radiotherapy for brain metastases
Joost Verhoeff, Netherlands
EDC04.4 Update on surgery for brain metastases
Rasheed Zakaria, United Kingdom
Chairs: tba
EDN03.1 COA for cognitive function
Isabelle Ryden, Sweden
EDN03.2 Use of Activities of Daily Living (IADL) Scale
Johan Koekkoek, Netherlands
EDN03.3 eHealth assesment: Goalsetting and quality of life
Iris Bras, Netherlands
EDN03.4 Navigated transcranial magnetic stimulation mapping
Ann-Kathrin Ohlerth, Netherlands
EDN03.5 Patient-reported outcomes and imaging analysis
Tomas Gomez, Sweden
15:20-15:35 hrs | BREAK
15:35-16:35 hrs
Chairs: tba
EDB05.1 Principles for Clinical Translation of AI in Neuro-Oncology
Spyridon Bakas, United States
EDB05.2 DNA methylation-based classification of brain tumors
Abigail Suwala, Germany
EDB05.3 Bayesian statistics and adaptive trial designs
Haiyan Zheng, United Kingdom
Chairs: tba
EDC05.1 The promise of radiomics and AI
Philipp Lohmann, Germany
EDC05.2 Functional mapping
Jane Skjøth-Rasmussen, Denmark
EDC05.3 New advanced MRI techniques for brain tumours
Julia Furtner-Srajer, Austria
Chairs: tba
EDN04.1 Roles and responsibilities in a multidisciplinary team/ Perspectives from the field of physiotherapy
Caroline Kelly, United Kingdom
EDN04.2 Setting up a supportive care clinic
Ingela Oberg, United Kingdom
EDN04.3 Strengthen your neuro-oncological network - A panel debate (with NAC committee)
Lena Rosenlund, Sweden
EDN04.4 Future work and closing remarks
Lena Rosenlund, Sweden
EANO Meeting - Thursday, September 21, 2023
17:00-18:00 hrs
Chairs: tba
JS01.1 Treatment of intracranial ependymoma with proton therapy
Sarah Peters, Germany
JS01.2 Surgical treatment of cranial ependymomas (adult and childhood)
Jens Gempt, Germany
Chairs: tba
OS01.1 Clinical studies of cannabinoids in adults and pediatric tumors
Chris Twelves, United Kingdom
OS01.2 Pre clinical data on cannabinoids in brain tumor models
Bozena Kaminska, Poland
OS01.3 Use of cannabinoids for comfort purposes
Martin Klein, Netherlands
Chairs: tba
PD01.1 Cancer Neuroscience: what really matters
Frank Winkler, Germany
PD01.2 Brain metastasis: what really matters
Adrienne Boire, United States
